Targeting FKBP isoforms with small-molecule ligands

Current Opinion in Pharmacology

Volumn 11, Issue 4, 2011, Pages 365-371

  Blackburn, Elizabeth A ^a   Walkinshaw, Malcolm D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; DM CHX; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 12; FK 506 BINDING PROTEIN 12.6; FK 506 BINDING PROTEIN 13; FK 506 BINDING PROTEIN 133; FK 506 BINDING PROTEIN 19; FK 506 BINDING PROTEIN 22; FK 506 BINDING PROTEIN 23; FK 506 BINDING PROTEIN 25; FK 506 BINDING PROTEIN 36; FK 506 BINDING PROTEIN 38; FK 506 BINDING PROTEIN 51; FK 506 BINDING PROTEIN 52; FK 506 BINDING PROTEIN 60; FK 506 BINDING PROTEIN 65; ISOMERASE INHIBITOR; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG; V 10367;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; DRUG BINDING SITE; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG TARGETING; HUMAN; NEUROTROPISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE;

EID: 80051668635     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.04.007     Document Type: Review

References (45)

1. J.A. Somarelli, S.Y. Lee, J. Skolnick, and R.J. Herrera Structure-based classification of 45 FK506-binding proteins Proteins 72 2008 197 208 (Pubitemid 351809158)
2. A. Galat Functional drift of sequence attributes in the FK506-binding proteins (FKBPs) J Chem Inf Model 48 2008 1118 1130
3. M.T. Ivery Immunophilins: switched on protein binding domains? Med Res Rev 20 2000 452 484
4. R. Himukai, T. Kuzuhara, and M. Horikoshi Relationship between the subcellular localization and structures of catalytic domains of FKBP-type PPIases J Biochem 126 1999 879 888
5. C.B. Kang, Y. Hong, S. Dhe-Paganon, and H.S. Yoon FKBP family proteins: immunophilins with versatile biological functions Neurosignals 16 2008 318 325
6. B.E. Bierer, P.S. Mattila, R.F. Standaert, L.A. Herzenberg, S.J. Burakhoff, G. Crabtree, and S.L. Schreiber Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin Proc Natl Acad Sci 87 1990 9231 9235 (Pubitemid 120030599)
7. E.M. Driggers, S.P. Hale, J. Lee, and N.K. Terrett The exploration of macrocycles for drug discovery - an underexploited structural class Nat Rev Drug Discov 7 2008 608 624 (Pubitemid 351927725)
8. S.F. Altschul, T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D.J. Lipman Gapped BLAST and PSI-BLAST: a new generation of protein database search programs Nucleic Acids Res 25 1997 3389 3402 (Pubitemid 27359211)
9. K.D. Pruitt, T. Tatusova, and D.R. Maglott NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins Nucleic Acids Res 35 2007 D61 D65
10. M.A. Larkin, G. Blackshields, N.P. Brown, R. Chenna, P.A. McGettigan, H. McWilliam, F. Valentin, I.M. Wallace, A. Wilm, and R. Lopez Clustal W and Clustal X version 2.0 Bioinformatics 23 2007 2947 2948 (Pubitemid 350162903)
11. B.G. Gold Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders Expert Opin Investig Drugs 9 2000 2331 2342
12. M. Gerard, A. Deleersnijder, V. Daniels, S. Schreurs, S. Munck, V. Reumers, H. Pottel, Y. Engelborghs, C. Van den Haute, and J.M. Taymans Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology J Neurosci 30 2010 2454 2463
13. S. Szep, S. Park, E.T. Boder, G.D. Van Duyne, and J.G. Saven Structural coupling between FKBP12 and buried water Proteins 74 2009 603 611
14. M. Magrane, and Consortium U UniProt Knowledgebase: a hub of integrated protein data Database (Oxford) 2011 2011 bar009
15. D.A. Peattie, M.W. Harding, M.A. Fleming, M.T. DeCenzo, J.A. Lippke, D.J. Livingston, and M. Benasutti Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes Proc Natl Acad Sci U S A 89 1992 10974 10978
16. H. Ashkenazy, E. Erez, E. Martz, T. Pupko, and N. Ben-Tal ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids Nucleic Acids Res 38 2010 W529 W533
17. R.E. Babine, and S.L. Bender Molecular recognition of protein-ligand complexes: applications to drug design Chem Rev 97 1997 1359 1472 (Pubitemid 127659602)
18. J. Dornan, P. Taylor, and M.D. Walkinshaw Structures of immunophilins and their ligand complexes Curr Top Med Chem 3 2003 1392 1409
19. X.J. Wang, and F.A. Etzkorn Peptidyl-prolyl isomerase inhibitors Biopolymers 84 2006 125 146
20. C. Christner, T. Herdegen, and G. Fischer FKBP ligands as novel therapeutics for neurological disorders Mini Rev Med Chem 1 2001 377 397
21. C. Choi, J.H. Li, M. Vaal, C. Thomas, D. Limburg, Y.Q. Wu, Y. Chen, R. Soni, C. Scott, and D.T. Ross Use of parallel-synthesis combinatorial libraries for rapid identification of potent FKBP12 inhibitors Bioorg Med Chem Lett 12 2002 1421 1428 (Pubitemid 34454826)
22. C. Guo, L. Dong, S. Kephart, and X. Hou An efficient synthesis of sulfamides Tetrahedron Lett 51 2010 2909 2913
23. K. Mahendrarajah, P.A. Dalby, B. Wilkinson, S.E. Jackson, and E.R. Main A high-throughput fluorescence chemical denaturation assay as a general screen for protein-ligand binding Anal Biochem 411 2011 155 157
24. M. Gaudet, N. Remtulla, S.E. Jackson, E.R. Main, D.G. Bracewell, G. Aeppli, and P.A. Dalby Protein denaturation and protein:drugs interactions from intrinsic protein fluorescence measurements at the nanolitre scale Protein Sci 19 2010 1544 1554
25. E.A. Blackburn, J.K. Maclean, B.S. Sherborne, and M.D. Walkinshaw Estimating the affinity of protein-ligand complex from changes to the charge-state distribution of a protein in electrospray ionization mass spectrometry Biochem Biophys Res Commun 403 2010 190 193
26. C. Juli, M. Sippel, J. Jager, A. Thiele, M. Weiwad, K. Schweimer, P. Rosch, M. Steinert, C.A. Sotriffer, and U. Holzgrabe Pipecolic acid derivatives as small-molecule inhibitors of the legionella MIP protein J Med Chem 54 2011 277 283
27. F. Sun, P. Li, Y. Ding, L. Wang, M. Bartlam, C. Shu, B. Shen, H. Jiang, S. Li, and Z. Rao Design and structure-based study of new potential FKBP12 inhibitors Biophys J 85 2003 3194 3201 (Pubitemid 37345806)
28. L. Wei, Y. Wu, D.E. Wilkinson, Y. Chen, R. Soni, C. Scott, D.T. Ross, H. Guo, P. Howorth, and H. Valentine Solid-phase synthesis of FKBP12 inhibitors: N-sulfonyl and N-carbamoylprolyl/pipecolyl amides Bioorg Med Chem Lett 12 2002 1429 1433 (Pubitemid 34454827)
29. D.A. Holt, J.I. Luengo, D.S. Yamashita, H.J. Oh, A.L. Konialian, H.K. Yen, L.W. Rozamus, M. Brandt, and M.J. Bossard Design, synthesis, and kinetic evaluation of high-affinity FKBP ligands and the X-ray crystal structures of their complexes with FKBP12 J Am Chem Soc 115 1993 9925 9938
30. P. Li, L. Wang, Y. Ding, B. Wu, C. Shu, A. Nie, S. Li, B. Shen, and Z. Rao Crystallization and preliminary X-ray diffraction analysis of FKBP12 complexed with a novel neurotrophic ligand Protein Pept Lett 9 2002 459 463 (Pubitemid 35036618)
31. C. Kozany, A. Marz, C. Kress, and F. Hausch Fluorescent probes to characterise FK506-binding proteins Chembiochem 10 2009 1402 1410
32. F. Edlich, M. Weiwad, D. Wildemann, F. Jarczowski, S. Kilka, M.C. Moutty, G. Jahreis, C. Lucke, W. Schmidt, F. Striggow, and G. Fischer The specific FKBP38 inhibitor N-(N′,N′-dimethylcarboxamidomethyl)cycloheximide has potent neuroprotective and neurotrophic properties in brain ischemia J Biol Chem 281 2006 14961 14970 (Pubitemid 43855200)
33. C. Sich, S. Improta, D.J. Cowley, C. Guenet, J.P. Merly, M. Teufel, and V. Saudek Solution structure of a neurotrophic ligand bound to FKBP12 and its effects on protein dynamics Eur J Biochem 267 2000 5342 5355
34. R.A. Hudack Jr, N.S. Barta, C. Guo, J. Deal, L. Dong, L.K. Fay, B. Caprathe, A. Chatterjee, D. Vanderpool, and C. Bigge Design, synthesis, and biological activity of novel polycyclic aza-amide FKBP12 ligands J Med Chem 49 2006 1202 1206 (Pubitemid 43221667)
35. J. Fanghanel, and G. Fischer Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases Front Biosci 9 2004 3453 3478
36. G. Zoldak, T. Aumuller, C. Lucke, J. Hritz, C. Oostenbrink, G. Fischer, and F.X. Schmid A library of fluorescent peptides for exploring the substrate specificities of prolyl isomerases Biochemistry (Mosc) 48 2009 10423 10436
37. R.K. Harrison, and R.L. Stein Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes Biochemistry (Mosc) 29 1990 3813 3816 (Pubitemid 20151288)
38. J.L. Kofron, P. Kuzmic, V. Kishore, E. Colon-Bonilla, and D.H. Rich Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay Biochemistry (Mosc) 30 1991 6127 6134
39. T. Mori, S. Itami, T. Yanagi, Y. Tatara, M. Takamiya, and T. Uchida Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors J Biomol Screen 14 2009 419 424
40. T. Mori, M. Hidaka, Y.C. Lin, I. Yoshizawa, T. Okabe, S. Egashira, H. Kojima, T. Nagano, M. Koketsu, M. Takamiya, and T. Uchida A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method Biochem Biophys Res Commun 406 2011 439 443
41. S.B. Shuker, P.J. Hajduk, R.P. Meadows, and S.W. Fesik Discovering high-affinity ligands for proteins: SAR by NMR Science 274 1996 1531 1534 (Pubitemid 26403929)
42. J.L. Stebbins, Z. Zhang, J. Chen, B. Wu, A. Emdadi, M.E. Williams, J. Cashman, and M. Pellecchia Nuclear magnetic resonance fragment-based identification of novel FKBP12 inhibitors J Med Chem 50 2007 6607 6617 (Pubitemid 350309098)
43. C.H. Rohrig, C. Loch, J.Y. Guan, G. Siegal, and M. Overhand Fragment-based synthesis and SAR of modified FKBP ligands: influence of different linking on binding affinity ChemMedChem 2 2007 1054 1070
44. P. Burkhard, U. Hommel, M. Sanner, and M.D. Walkinshaw The discovery of steroids and other novel FKBP inhibitors using a molecular docking program J Mol Biol 287 1999 853 858 (Pubitemid 29188872)
45. S. Romano, P.A. Di, A. Sorrentino, R. Bisogni, L. Sivero, and M.F. Romano FK506 binding proteins as targets in anticancer therapy Anticancer Agents Med Chem 10 2010 651 656